Summary
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
The report includes as follows:
The report provides current data, historical overview and future forecast.
The report includes an in-depth analysis of the Global market for Oral Vaccines , covering Global total and major region markets.
The data of 2017-2025 are included. All-inclusive market are given through data on sales, consumption, and prices (Global total and by major regions).
The report provides introduction of leading Global manufacturers.
Oral Vaccines market prospects to 2025 are included (in sales, consumption and price).
Market Segment as follows:
By Region / Countries
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc)
Asia-Pacific (China, India, Japan, Southeast Asia etc)
South America (Brazil, Argentina etc)
Middle East & Africa (Saudi Arabia, South Africa etc)
By Type
Live Attenuated Vaccines
Killed/Inactivated Vaccines
Recombinant Vaccines
Others
By End-User / Application
Polio
Rabies
Rotavirus
Cholera
HIV
Respiratory Infections
Influenza
Tuberculosis
Others
By Company
GlaxoSmithKline Plc.
PaxVax Corporation
Pfizer Inc
Merial, Inc.
Merck Sharp & Dohme Corp
VALNEVA Canada Inc.
QUíMICA SUIZA S.A
Immunitor, Inc
Aventis (Sanofi S.A.)
Serum Institute of India Pvt. Ltd
Swiss Serum and Vaccine Institute Berne
Bull Bio - NCIPD Ltd.
Vaxart, Inc.
Shantha Biotechnics
Crucell (Janssen Global Services, LLC)
Table of Contents
Part 1 Market Definition
1.1 Market Segment Overview
Figure Global Oral Vaccines Market Size (Million USD) 2017-2025
1.2 by Type
Table Global Oral Vaccines Market and Growth by Type
1.3 by End-Use / Application
Table Global Oral Vaccines Market and Growth by End-Use / Application
2 Global Market by Vendors
2.1 Market Share
Table Global Oral Vaccines Revenue (Million USD) by Vendors (2017-2019)
Table Global Oral Vaccines Revenue Share by Vendors (2017-2019)
Table Global Oral Vaccines Market Volume (Volume) by Vendors (2017-2019)
Table Global Oral Vaccines Market Volume Share by Vendors (2017-2019)
2.2 Vendor Profile
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
2.3 Dynamic of Vendors
3 Global Market by Type
3.1 Market Share
Table Global Oral Vaccines Market (Million USD) by Type (2017-2019)
Table Global Oral Vaccines Market Share by Type (2017-2019)
Table Global Oral Vaccines Market Volume (Volume) by Type (2017-2019)
Table Global Oral Vaccines Market Volume Share by Type (2017-2019)
3.2 Introduction of End-Use by Different Products
4 Global Market by End-Use / Application
4.1 Market Share
Table Global Oral Vaccines Market (Million USD) by End-Use / Application (2017-2019)
Table Global Oral Vaccines Market Share by End-Use / Application (2017-2019)
Table Global Oral Vaccines Market Volume (Volume) by End-Use / Application (2017-2019)
Table Global Oral Vaccines Market Volume Share by End-Use / Application (2017-2019)
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs
5 Global Market by Regions
5.1 Market Share
Table Global Oral Vaccines Market (Million USD) by Regions (2017-2019)
Table Global Oral Vaccines Market Share by Regions (2017-2019)
Table Global Oral Vaccines Market Volume (Volume) by Regions (2017-2019)
Table Global Oral Vaccines Market Volume Share by Regions (2017-2019)
5.2 Regional Market Growth
5.2.1 North America
Figure North America Market Growth 2015-2018
5.2.2 Europe
Figure Europe Market Growth 2017-2019
5.2.3 Asia-Pacific
Figure Asia-Pacific Market Growth 2017-2019
5.2.4 South America
Figure South America Market Growth 2017-2019
5.2.5 Middle East & Africa
Figure Middle East & Africa Market Growth 2017-2019
6 North America Market
6.1 by Type
Table North America Oral Vaccines Market (Million USD) by Type (2017-2019)
Table North America Oral Vaccines Market Share by Type (2017-2019)
6.2 by End-Use / Application
Table North America Oral Vaccines Market (Million USD) by End-Use / Application (2017-2019)
Table North America Oral Vaccines Market Share by End-Use / Application (2017-2019)
6.3 by Regions
Table North America Oral Vaccines Market (Million USD) by Regions (2017-2019)
Table North America Oral Vaccines Market Share by Regions (2017-2019)
7 Europe Market
7.1 by Type
Table Europe Oral Vaccines Market (Million USD) by Type (2017-2019)
Table Europe Oral Vaccines Market Share by Type (2017-2019)
7.2 by End-Use / Application
Table Europe Oral Vaccines Market (Million USD) by End-Use / Application (2017-2019)
Table Europe Oral Vaccines Market Share by End-Use / Application (2017-2019)
7.3 by Regions
Table Europe Oral Vaccines Market (Million USD) by Regions (2017-2019)
Table Europe Oral Vaccines Market Share by Regions (2017-2019)
8 Asia-Pacific Market
8.1 by Type
Table Asia-Pacific Oral Vaccines Market (Million USD) by Type (2017-2019)
Table Asia-Pacific Oral Vaccines Market Share by Type (2017-2019)
8.2 by End-Use / Application
Table Asia-Pacific Oral Vaccines Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific Oral Vaccines Market Share by End-Use / Application (2017-2019)
8.3 by Regions
Table Asia-Pacific Oral Vaccines Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific Oral Vaccines Market Share by Regions (2017-2019)
9 South America Market
9.1 by Type
Table South America Oral Vaccines Market (Million USD) by Type (2017-2019)
Table South America Oral Vaccines Market Share by Type (2017-2019)
9.2 by End-Use / Application
Table South America Oral Vaccines Market (Million USD) by End-Use / Application (2017-2019)
Table South America Oral Vaccines Market Share by End-Use / Application (2017-2019)
9.3 by Regions
Table South America Oral Vaccines Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Oral Vaccines Market Share by Regions (2017-2019)
10 Middle East & Africa Market
10.1 by Type
Table Middle East & Africa Oral Vaccines Market (Million USD) by Type (2017-2019)
Table Middle East & Africa Oral Vaccines Market Share by Type (2017-2019)
10.2 by End-Use / Application
Table Middle East & Africa Oral Vaccines Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa Oral Vaccines Market Share by End-Use / Application (2017-2019)
10.3 by Regions
Table Middle East & Africa Oral Vaccines Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Oral Vaccines Market Share by Regions (2017-2019)
11 Market Forecast
11.1 Global Market Forecast (2020-2025)
Figure Global Oral Vaccines Market (Million USD) and Growth Forecast (2020-2025)
Figure Global Oral Vaccines Market Volume (Volume) and Growth Forecast (2020-2025)
11.2 Market Forecast by Regions (2020-2025)
Table Global Oral Vaccines Market (Million USD) Forecast by Regions (2020-2025)
Table Global Oral Vaccines Market Share Forecast by Regions (2020-2025)
Table Global Oral Vaccines Market Volume (Volume) Forecast by Regions (2020-2025)
Table Global Oral Vaccines Market Volume Share Forecast by Regions (2020-2025)
11.3 Market Forecast by Type (2020-2025)
Table Global Oral Vaccines Market (Million USD) Forecast by Type (2020-2025)
Table Global Oral VaccinesMarket Share by Forecast Type (2020-2025)
11.4 Market Forecast by End-Use / Application (2020-2025)
Table Global Oral Vaccines Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global Oral Vaccines Market Share Forecast by End-Use / Application (2020-2025)
12 Key Manufacturers
12.Alcatel-Lucent GlaxoSmithKline Plc.
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Table Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline Plc.
12.2 PaxVax Corporation
12.3 Pfizer Inc
12.4 Merial, Inc.
12.5 Merck Sharp & Dohme Corp
12.6 VALNEVA Canada Inc.
12.7 QUíMICA SUIZA S.A
12.8 Immunitor, Inc
12.9 Aventis (Sanofi S.A.)
12.10 Serum Institute of India Pvt. Ltd
12.11 Swiss Serum and Vaccine Institute Berne
12.12 Bull Bio - NCIPD Ltd.
12.13 Vaxart, Inc.
12.14 Shantha Biotechnics
12.15 Crucell (Janssen Global Services, LLC)
13 Overview of Industry Development (COVID-19)
13.1 Analysis of Industry Development (COVID-19)
13.2 Industry Development Stage (COVID-19)
13.3 General Situation of Industry Development (COVID-19)
13.4 Analysis of Industry Development Characteristics (COVID-19)
14 Research Conclusion
The Vaccines Isothermal Boxes Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufactu...
This report gives an insight into the global Sleep Apnea Oral Appliances Market and predicts the future growth prospects and the trends that may exhibit in the market during the period of 2023-2030. The future growth has been calculated by taking into account the present growth rate and the overall ...
Asia Pacific preventive vaccines market will grow by 7.9% annually with a total addressable market cap of $217.46 billion over 2023-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for p...
Europe preventive vaccines market was valued at $18.02 billion in 2022 and will grow by 5.1% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines s...
North America preventive vaccines market is projected to grow by 6.3% annually in the forecast period and reach $46.90 billion by 2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for pre...
Global preventive vaccines market will reach $120.07 billion by 2032, growing by 6.4% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines such as ...
Overview of the Global Potassium Chloride Oral Solution Market:
The report discusses everything a marketer requires before investing in the global Potassium Chloride Oral Solution Market during the forecast period 2...
The global Liquid Paraffin Oral Emulsion market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market player...
The global Oral hypoglycemic agents and insulin analogues market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will h...
The global Human Rabies Vaccines market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in thi...